Coeptis Therapeutics Holdings Management
Management criteria checks 3/4
Coeptis Therapeutics Holdings' CEO is Dave Mehalick, appointed in Oct 2016, has a tenure of 7.92 years. total yearly compensation is $360.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 6.55% of the company’s shares, worth $442.74K. The average tenure of the management team and the board of directors is 2.5 years and 2.7 years respectively.
Key information
Dave Mehalick
Chief executive officer
US$360.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 7.9yrs |
| CEO ownership | 6.5% |
| Management average tenure | 2.5yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$16m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$360k | US$360k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$20m |
| Jun 30 2023 | n/a | n/a | -US$20m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$362k | US$287k | -US$38m |
| Sep 30 2022 | n/a | n/a | -US$37m |
| Jun 30 2022 | n/a | n/a | -US$38m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$217k | US$217k | -US$13m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$9m |
| Dec 31 2020 | US$149k | US$149k | -US$9m |
| Dec 31 2019 | US$147k | US$147k | -US$2m |
Compensation vs Market: Dave's total compensation ($USD360.00K) is below average for companies of similar size in the US market ($USD677.23K).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Mehalick (55 yo)
7.9yrs
Tenure
US$360,000
Compensation
Mr. David Mehalick, also known as Dave, is Chief Business Officer at Sparta Healthcare Acquisition Corp. He is a co-founder of Coeptis Therapeutics Holdings, Inc. (formerly known as Coeptis Therapeutics, I...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 7.9yrs | US$360.00k | 6.55% $ 442.7k | |
| Co-Founder and VP of Compliance & Corporate Secretary | 3.6yrs | US$151.00k | 2.54% $ 172.0k | |
| Co-Founder | no data | US$360.00k | 2.54% $ 172.0k | |
| Chief Financial Officer | 1.3yrs | US$208.00k | no data | |
| CSO & Chief Medical Officer | 1.1yrs | US$360.00k | no data |
2.5yrs
Average Tenure
55yo
Average Age
Experienced Management: COEP's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3.6yrs | US$360.00k | 6.55% $ 442.7k | |
| Co-Founder | 3.6yrs | US$360.00k | 2.54% $ 172.0k | |
| Independent Director | 1.9yrs | no data | no data | |
| Independent Director | 1.9yrs | no data | no data | |
| Independent Director | 1.9yrs | no data | 0.21% $ 14.3k | |
| Independent Director | 7.7yrs | no data | 1.27% $ 85.7k | |
| Member of Scientific & Clinical Advisory Board | 2.7yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 2.7yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 2.7yrs | no data | no data | |
| Independent Director | 1.9yrs | no data | no data |
2.7yrs
Average Tenure
55yo
Average Age
Experienced Board: COEP's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.